REVA Completes Clinical Enrollment Milestone

SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) is pleased to announce that it has enrolled the first cohort of 110 patients in the FANTOM II clinical trial. Achievement of this milestone is key to the Company’s planned CE Mark...